(E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine

C21H17FN4O4S — CID 15869675

IUPAC(E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine
SMILESCO/N=C(/C1=NOCCS1)c1ccccc1Oc1ncnc(Oc2ccccc2)c1F
InChIInChI=1S/C21H17FN4O4S/c1-27-25-18(21-26-28-11-12-31-21)15-9-5-6-10-16(15)30-20-17(22)19(23-13-24-20)29-14-7-3-2-4-8-14/h2-10,13H,11-12H2,1H3/b25-18+
InChIKeySGLVVSSFUKMMNW-XIEYBQDHSA-N
MW440.46 g/mol
LogP4.63
Rot. Bonds7

About (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine

(E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine (PubChem CID 15869675) has the molecular formula C21H17FN4O4S and a molecular weight of 440.46 g/mol. Its IUPAC name is (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine.

Molecular Properties

Compound Name(E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine
PubChem CID15869675
Molecular FormulaC21H17FN4O4S
Molecular Weight440.46 g/mol
Exact Mass440.10
IUPAC Name(E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine
SMILESCO/N=C(/C1=NOCCS1)c1ccccc1Oc1ncnc(Oc2ccccc2)c1F
InChIInChI=1S/C21H17FN4O4S/c1-27-25-18(21-26-28-11-12-31-21)15-9-5-6-10-16(15)30-20-17(22)19(23-13-24-20)29-14-7-3-2-4-8-14/h2-10,13H,11-12H2,1H3/b25-18+
InChIKeySGLVVSSFUKMMNW-XIEYBQDHSA-N
XLogP4.63
TPSA87.42 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500440.46
LogP ≤ 54.63
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine?
The IUPAC name of (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine (CID 15869675) is (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine.
What is the SMILES notation for (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine?
The canonical SMILES for (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine is CO/N=C(/C1=NOCCS1)c1ccccc1Oc1ncnc(Oc2ccccc2)c1F.
What is the InChIKey of (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine?
The InChIKey is SGLVVSSFUKMMNW-XIEYBQDHSA-N. The full InChI is InChI=1S/C21H17FN4O4S/c1-27-25-18(21-26-28-11-12-31-21)15-9-5-6-10-16(15)30-20-17(22)19(23-13-24-20)29-14-7-3-2-4-8-14/h2-10,13H,11-12H2,1H3/b25-18+.
What are the key properties of (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine?
(E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine has a molecular weight of 440.46 g/mol, XLogP of 4.63, 7 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-1-(5,6-dihydro-1,4,2-oxathiazin-3-yl)-1-[2-(5-fluoro-6-phenoxypyrimidin-4-yl)oxyphenyl]-N-methoxymethanimine is sourced from PubChem (CID 15869675), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).